mRNA 新冠病毒疫苗延长接种间隔的免疫原性。
Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals.
机构信息
Department of Emergency Medicine, University of British Columbia, Vancouver, Canada.
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
出版信息
JAMA. 2022 Jan 18;327(3):279-281. doi: 10.1001/jama.2021.21921.
Abstract
This study investigates the immunogenicity of extended mRNA vaccine dosing intervals.
摘要
本研究探讨了延长 mRNA 疫苗接种间隔的免疫原性。
相似文献
1
Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals.mRNA 新冠病毒疫苗延长接种间隔的免疫原性。
JAMA. 2022 Jan 18;327(3):279-281. doi: 10.1001/jama.2021.21921.
2
Correlation of vaccine-elicited antibody levels and neutralizing activities against SARS-CoV-2 and its variants.疫苗诱导产生的抗体水平与针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）及其变体的中和活性之间的相关性。
Clin Transl Med. 2021 Dec;11(12):e644. doi: 10.1002/ctm2.644.
3
Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2.针对 SARS-CoV-2 的三种不同疫苗加强免疫后的抗体反应动力学。
Front Immunol. 2022 Jan 19;13:811020. doi: 10.3389/fimmu.2022.811020. eCollection 2022.
4
Antibody Responses after SARS-CoV-2 Vaccination in Patients with Liver Diseases.肝病人群接种 SARS-CoV-2 疫苗后的抗体反应。
Viruses. 2022 Jan 21;14(2):207. doi: 10.3390/v14020207.
5
Response to mRNA vaccination for COVID-19 among patients with multiple myeloma.mRNA 疫苗接种对多发性骨髓瘤患者 COVID-19 的反应。
Leukemia. 2021 Dec;35(12):3534-3541. doi: 10.1038/s41375-021-01354-7. Epub 2021 Jul 29.
6
Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.尽管接种了mRNA疫苗加强针，但仍出现了新冠病毒奥密克戎变异株突破性感染。
Lancet. 2022 Feb 12;399(10325):625-626. doi: 10.1016/S0140-6736(22)00090-3. Epub 2022 Jan 18.
7
Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines.评估新冠疫苗需要标准化的中和抗体检测。
EBioMedicine. 2021 Nov;73:103677. doi: 10.1016/j.ebiom.2021.103677. Epub 2021 Nov 3.
8
COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer.新冠病毒mRNA加强疫苗对癌症患者抵御新冠病毒奥密克戎变种有很强的保护作用。
Cancer Cell. 2022 Feb 14;40(2):117-119. doi: 10.1016/j.ccell.2021.12.014. Epub 2021 Dec 30.
9
Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex.SARS-CoV-2 mRNA 疫苗接种后的抗体亲和力成熟和跨变体活性：既往暴露和性别的影响。
EBioMedicine. 2021 Dec;74:103748. doi: 10.1016/j.ebiom.2021.103748. Epub 2021 Dec 10.
10
"COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment".“COVID-19/SARS-CoV-2 病毒刺突蛋白相关的透明质酸真皮填充剂延迟性炎症反应：诊断和治疗中的具有挑战性的临床难题”。
Arch Dermatol Res. 2022 Jan;314(1):1-15. doi: 10.1007/s00403-021-02190-6. Epub 2021 Feb 9.
引用本文的文献
1
Functional antibody responses to SARS-CoV-2 variants before and after booster vaccination among adults in Ghana.加纳成年人加强免疫前后对新冠病毒变异株的功能性抗体反应。
Exp Biol Med (Maywood). 2025 Jul 21;250:10440. doi: 10.3389/ebm.2025.10440. eCollection 2025.
2
Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-19 vaccination.免疫印记和疫苗接种间隔决定了对单价XBB.1.5新冠疫苗接种的抗体反应。
Commun Med (Lond). 2025 May 17;5(1):182. doi: 10.1038/s43856-025-00898-4.
3
Improved antibody breadth with an extended primary dose interval of COVID-19 vaccine is overcome by boosters.新冠疫苗延长初次接种间隔可提高抗体广度，但这种效果会被加强针所克服。
Front Immunol. 2025 Mar 27;16:1529134. doi: 10.3389/fimmu.2025.1529134. eCollection 2025.
4
Immunologic assessment of the impact of SARS-CoV-2 vaccine booster doses on humoral immunity: a cross-sectional study in morocco.SARS-CoV-2疫苗加强剂量对体液免疫影响的免疫学评估：摩洛哥的一项横断面研究
BMC Infect Dis. 2024 Dec 28;24(1):1470. doi: 10.1186/s12879-024-10345-9.
5
Impact of Prolonged SARS-CoV-2 Dosing Interval in Hemodialysis Patients.延长严重急性呼吸综合征冠状病毒2（SARS-CoV-2）给药间隔对血液透析患者的影响。
Kidney Int Rep. 2024 Jun 24;9(8):2575-2577. doi: 10.1016/j.ekir.2024.04.072. eCollection 2024 Aug.
6
Long Prime-Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer Vaccine.长的初免-加强间隔与对碳水化合物癌症疫苗的抗GD2抗体反应增强
Vaccines (Basel). 2024 May 28;12(6):587. doi: 10.3390/vaccines12060587.
7
Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection.单次 MVA-SARS-2-ST/N 疫苗接种可迅速保护 K18-hACE2 小鼠免受致死性 SARS-CoV-2 挑战感染。
Viruses. 2024 Mar 8;16(3):417. doi: 10.3390/v16030417.
8
Factors impacting antibody kinetics, including fever and vaccination intervals, in SARS-CoV-2-naïve adults receiving the first four mRNA COVID-19 vaccine doses.影响 SARS-CoV-2 初免成年人接受前四剂 mRNA COVID-19 疫苗时抗体动力学的因素，包括发热和疫苗接种间隔。
Sci Rep. 2024 Mar 27;14(1):7217. doi: 10.1038/s41598-024-57931-0.
9
The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study.剂量间隔对COVID-19 mRNA疫苗抗体反应的影响：一项前瞻性队列研究。
Front Immunol. 2024 Feb 16;15:1330549. doi: 10.3389/fimmu.2024.1330549. eCollection 2024.
10
Rapid transient and longer-lasting innate cytokine changes associated with adaptive immunity after repeated SARS-CoV-2 BNT162b2 mRNA vaccinations.与重复接种 SARS-CoV-2 BNT162b2 mRNA 疫苗后适应性免疫相关的快速瞬时和更持久的固有细胞因子变化。
Front Immunol. 2023 Nov 27;14:1292568. doi: 10.3389/fimmu.2023.1292568. eCollection 2023.
Zotero 插件